Moreover, we observed a significant ES event of LRRFIP1 in the ICU cohort (p = 0.009), suggesting that AS of LRRFIP1 is a prevalent signature in severe COVID-19 patients. This evidence concerns the gene LRRFIP1 and COVID-19.